Results 31 to 40 of about 1,182,904 (110)

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy. [PDF]

Transplant Cell Ther
Sharma A, Kassim A, Thompson A, Williams DA, Liu HD, Boelens JJ, LaBelle JL, Tisdale J, de la Fuente J, Kanter J, Krishnamurti L, Pecker LH, Walters MC, Eapen M, Porteus M, Bhatia M, Soni S, Corbacioglu S, John TD, Cancio MI.   +19 more
europepmc   +1 more source

Advancing dual gene therapy for SFTPC deficiency. [PDF]

Mol Ther
Clark RDE, Hanna M, Kolls JK.
europepmc   +1 more source

The status of cell and gene therapy education in medical schools-An international survey. [PDF]

Transfusion
Wappler-Guzzetta EA, Tabacu AM, Nedelcu E.   +2 more
europepmc   +1 more source

Editorial: Gene editing in cancer gene therapy. [PDF]

Front Med (Lausanne)
Hou Y, Zhou Y, Wang K, Xia X.
europepmc   +1 more source

Cell and Gene Therapy in Equine Ocular Disease. [PDF]

Vet Ophthalmol
Young KAS, Schnabel LV, Gilger BC.
europepmc   +1 more source

Six-year FIX-padua gene therapy in hemophilia B. [PDF]

Blood Adv
Miesbach W, Herzog R.
europepmc   +1 more source

Gene Therapy of Beta Hemoglobinopathies. [PDF]

Biomedicines
Testa U, Pelosi E, Castelli G.
europepmc   +1 more source

Immune Toxicities in AAV Gene Therapy: Overview for Clinicians. [PDF]

Int J Mol Sci
Parajuli S, Gallagher T, Flotte TR.
europepmc   +1 more source

Considerations for the Use of AAV-based Gene Therapy in HIV-Positive Individuals With Haemophilia. [PDF]

Haemophilia
Rockstroh JK, Stingl JC, Stadler M, Reichert A, Wedemeyer H, Oldenburg J.   +5 more
europepmc   +1 more source

Lipid nanoparticles for cell and gene therapy. [PDF]

Mol Ther Adv
Han X, Shi Q, Mitchell MJ.
europepmc   +1 more source